Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Siemens    SIE   DE0007236101

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

Siemens AG : WSJ BLOG/Health : Siemens Sees Resurgence in Diagnostics as a Cost Cutter

share with twitter share with LinkedIn share with facebook
share via e-mail
04/13/2012 | 07:02pm CEST

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Shirley S. Wang

The Health Blog caught up at TEDMED with Gregory Sorensen, chief executive of Siemens Healthcare in North America, to talk about the changing health-care field and what it means for diagnostics, an area in which Siemens is a player.

"We're beginning to see resurgence in diagnostics as a way to save costs, " Sorensen, formerly a radiology professor at Harvard Medical School, told the Health Blog.

A missed diagnosis is a big cost driver in health care because it wastes time and money on ineffective therapy, he said, pointing to an example of studies in Alzheimer's showing that upon autopsy, some 15%-20% of patients examined had a different ailment than believed and would have been treated differently when they were alive.

Of course, there's been an outcry about the unnecessary use of medical tests and Sorensen acknowledges there has been overuse in the past. Reductions in Medicare reimbursement rates have curbed overuse, he says, though not everyone agrees on that, as the Health Blog reported last week. The important thing now, Sorensen says, is to make sure people are getting the right diagnostic tests, rather than reduce the absolute number of them.

He recalled being a doctor in training in the late 1980s, when his professors taught him that, because of the risks associated with appendicitis, doctors should be conservative whenever a patient reported pain in the lower right quadrant of the abdomen. A good surgeon, therefore, would do exploratory surgery on five patients for every one that actually had appendicitis. Sorensen himself had his appendix -- which turned out to be healthy -- removed during this era.

Now patients get scanned if they report such pain, resulting in many fewer unnecessary surgeries, said Sorensen.

Siemens recognizes how important it is to demonstrate effectiveness in today's health-care business, and that payers want to see results, says Sorensen. As for the shift to reimbursement for value, "that train has left the station."

 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on SIEMENS
04:00p SIEMENS AKTIENGESELLSCHAFT : Release of a capital market information
10/21 SIEMENS : Federal Contracts Awarded to Companies in Tennessee (Oct. 21)
10/21 SIEMENS : Federal Contracts Awarded by Federal Agencies in California (Oct. 21)
10/20 Exclusive - Iberdrola demanded change at Siemens Gamesa as problems mounted
10/20 Siemens Gamesa announces board reshuffle as problems mount
10/20 SIEMENS : $422,560 Federal Contract Awarded to PetNet Solutions
10/20 SIEMENSNPV : Siemens plan thousands of job cuts over two divisions
10/20 SIEMENSNPV : Siemens plan thousands of job cuts over two divisions
10/19 SIEMENS : Patent Issued for Electric Power Supply Network Linked to a Transport ..
10/19 SIEMENS : Patent Application Titled "Combined Shim and Bore Cooling Assembly" Pu..
More news
News from SeekingAlpha
10/20 REUTERS : Iberdrola concerned about Siemens management of wind power JV
10/20 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2017 Update
10/19 Siemens plans thousands of job cuts
10/18 Nokia Has No Growth Prospects At The Moment
10/17 Building A Clean Energy Portfolio; The Time Is At Hand
Financials (€)
Sales 2017 84 177 M
EBIT 2017 8 692 M
Net income 2017 6 388 M
Debt 2017 18 560 M
Yield 2017 3,27%
P/E ratio 2017 15,30
P/E ratio 2018 15,26
EV / Sales 2017 1,39x
EV / Sales 2018 1,31x
Capitalization 98 515 M
Duration : Period :
Siemens Technical Analysis Chart | SIE | DE0007236101 | 4-Traders
Technical analysis trends SIEMENS
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 130 €
Spread / Average Target 13%
EPS Revisions
Josef Kaeser President & Chief Executive Officer
Gerhard Cromme Chairman-Supervisory Board
Ralf Peter Thomas Chief Financial Officer
Roland Emil Busch Chief Technology Officer
Helmuth Ludwig Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
SIEMENS-0.77%116 080
3M23.94%132 077